| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |